Astropad Workbench vs Linear AI Triage Agent

“If you're running agents on a headless Mac Mini, this fills a real gap. The voice dictation-to-terminal feature alone saves constant context-switching. LIQUID protocol latency is noticeably better than Screens or Remotix on the same network. At $10/month it's easy to justify if you spend more than 2 hours a week babysitting agents.”

“The primitive is clear: a classifier-plus-router that runs on incoming issues using your team's historical label and assignment patterns as training signal. That's a real problem — triage queues are genuinely painful and the manual work is mind-numbing. The DX bet Linear made is correct: zero new config surface because it learns from what you've already done in Linear, not from YAML you have to write. The moment of truth is when the first real bug report comes in and gets silently miscategorized — that's where I'd probe — but the fact that it's embedded in the workflow rather than bolted on as a webhook or separate dashboard is the specific decision that earns the ship.”

“This is a premium wrapper on remote desktop technology that has been free for decades. SSH + tmux handles 90% of agent monitoring needs. The 20-minute free tier is aggressively limiting, and the $10/month bet assumes you'll always be near an iPhone or iPad — which developers with multiple monitors at a desk often won't be.”

“Direct competitors are GitHub Issues with third-party triage bots and Jira's own Smart Issue automation — neither is good, which is exactly why this has room to exist. The scenario where this breaks is small teams under 50 issues/month who don't have enough historical patterns to train on, and the first generation of outputs will be confidently wrong in ways that take longer to fix than manual triage. The prediction: this survives because Linear has the distribution and the workflow data moat — the triage agent gets genuinely better as your team uses Linear longer, which is the one defensibility story I actually believe. What would make me wrong: if Atlassian ships the same thing inside Jira and enterprises just don't switch.”

“Remote agent management from mobile is a genuine paradigm shift in how we relate to compute. As agents handle longer-horizon tasks, the supervision interface becomes as important as the agent itself. Workbench is an early bet on what 'agent oversight UX' looks like — and Apple's ecosystem is the right place to build it first.”

“Being able to review and approve agent outputs from an iPad while away from your desk is genuinely freeing. The Apple Pencil annotation for screen review is a nice touch — annotating a generated design or document in-context beats typing corrections in a chat interface.”

“The job-to-be-done is laser-focused: eliminate the manual triage step between bug report creation and engineer assignment. That's a single, complete job with a clear before-and-after state, and this product doesn't try to also be a sprint planner or a retrospective tool. Onboarding is near-zero for existing Linear users — the agent activates on your existing workspace data, which means value is visible within the first week without a configuration sprint. The specific product decision that earns the ship is that it routes based on historical patterns rather than asking the team to define routing rules upfront — that's the right opinion to have, because no team will maintain a routing config file.”

“The buyer is already inside Linear's billing relationship — this isn't a new sales motion, it's an expansion feature that makes the existing subscription stickier and raises the cost of switching to Jira or Shortcut. The moat is real and specific: the agent improves with your team's accumulated Linear data, so a team that's been on Linear for two years gets a dramatically better agent than a team that just migrated — that's genuine workflow lock-in, not fake lock-in. The stress test is whether Linear can hold the line on pricing when GitHub Copilot or Atlassian Intelligence ship triage as a bundled feature, and honestly the answer depends entirely on whether Linear's base product keeps winning on DX, which it has so far.”